Shuji Mikami Selected Research

Shuji Mikami Research Topics

Disease

71	Neoplasms (Cancer) 06/2022 - 08/2004
33	Renal Cell Carcinoma (Grawitz Tumor) 06/2022 - 07/2004
26	Carcinoma (Carcinomatosis) 06/2022 - 08/2004
19	Prostatic Neoplasms (Prostate Cancer) 07/2022 - 02/2010
17	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2008
10	Urinary Bladder Neoplasms (Bladder Cancer) 05/2022 - 01/2010
8	Adenocarcinoma 07/2022 - 01/2013
5	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2012
4	Lymphatic Metastasis 06/2022 - 08/2004
4	Disease Progression 10/2020 - 04/2013
3	Non-Muscle Invasive Bladder Neoplasms 05/2022 - 01/2016
3	Carcinoma in Situ 03/2021 - 03/2011
3	Hypoxia (Hypoxemia) 06/2018 - 09/2006
3	Kidney Neoplasms (Kidney Cancer) 02/2016 - 09/2008
3	Carcinogenesis 07/2015 - 07/2004
3	Adenoma (Adenomas) 01/2013 - 01/2008
2	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 06/2012
2	Hematuria 10/2021 - 05/2014
2	Necrosis 12/2019 - 01/2008
2	Cysts 12/2015 - 04/2014
1	Testicular Neoplasms (Testicular Cancer) 12/2021
1	Lung Neoplasms (Lung Cancer) 12/2021
1	Urinary Retention 10/2021
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2005
8	Biological ProductsIBA 05/2022 - 12/2010
8	PlatinumIBA 01/2022 - 11/2016
8	Indicators and Reagents (Reagents)IBA 03/2021 - 08/2012
7	Prostate-Specific Antigen (Semenogelase)IBA 07/2022 - 01/2014
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 10/2016
6	LigandsIBA 11/2021 - 06/2014
5	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 01/2018
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 08/2004
5	Protein Isoforms (Isoforms)IBA 04/2019 - 07/2004
4	Tyrosine Kinase InhibitorsIBA 11/2021 - 08/2012
4	Cadherins (E-Cadherin)IBA 11/2019 - 10/2011
4	Sunitinib (Sutent)FDA Link 01/2017 - 05/2012
4	heparanaseIBA 09/2016 - 08/2004
3	AndrogensIBA 07/2022 - 01/2021
3	C-Reactive ProteinIBA 08/2021 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2018 - 12/2006
3	Matrix Metalloproteinases (MMPs)IBA 09/2016 - 02/2010
3	Messenger RNA (mRNA)IBA 04/2015 - 09/2006
2	Anaplastic Lymphoma KinaseIBA 06/2022 - 01/2021
2	MucinsIBA 06/2022 - 10/2020
2	taxaneIBA 01/2022 - 11/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2012
2	Docetaxel (Taxotere)FDA Link 11/2021 - 05/2016
2	Etoposide (VP 16)FDA LinkGeneric 11/2021 - 12/2019
2	NivolumabIBA 08/2021 - 10/2019
2	Mucin-1 (CA 15-3 Antigen)IBA 10/2020 - 04/2010
2	enzalutamideIBA 10/2019 - 04/2016
2	Everolimus FDA Link 12/2016 - 05/2012
2	EnzymesIBA 09/2016 - 09/2014
2	Phosphotransferases (Kinase)IBA 02/2016 - 02/2016
2	tyrosine receptor (receptor, tyrosine)IBA 02/2016 - 02/2016
2	SmokeIBA 07/2015 - 02/2010
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 07/2015 - 02/2010
2	Small Interfering RNA (siRNA)IBA 07/2015 - 12/2010
2	Contrast MediaIBA 04/2014 - 11/2011
2	Capsules (Microcapsules)IBA 01/2014 - 08/2011
2	Keratin-7 (Cytokeratin 7)IBA 01/2014 - 08/2011
2	Angiotensin IIIBA 03/2012 - 02/2010
2	Hormones (Hormone)IBA 02/2010 - 01/2008
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2006 - 08/2004
1	alpha-methylacyl-CoA racemaseIBA 06/2022
1	Phenobarbital (Luminal)FDA Link 05/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Androgen Receptor AntagonistsIBA 01/2022
1	Radium-233IBA 01/2022
1	Co-Repressor ProteinsIBA 01/2022
1	AntigensIBA 12/2021
1	cabazitaxel FDA Link 11/2021
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2021
1	cabozantinibIBA 11/2021
1	Apoptosis Regulatory ProteinsIBA 08/2021
1	MAP Kinase Kinase Kinase 1IBA 05/2021
1	Abiraterone AcetateIBA 01/2021
1	abirateroneIBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 12/2020
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 10/2020
1	Oncogene Proteins (Oncogene Protein)IBA 10/2020

Therapy/Procedure

29	Therapeutics 07/2022 - 04/2008
11	Nephroureterectomy 05/2022 - 02/2009
9	Castration 07/2022 - 03/2012
9	Drug Therapy (Chemotherapy) 01/2022 - 06/2012
4	Radiotherapy 07/2022 - 07/2015
4	Immunotherapy 10/2021 - 09/2014
4	Lymph Node Excision (Lymph Node Dissection) 11/2014 - 02/2009
3	Brachytherapy 07/2022 - 05/2014
3	Aftercare (After-Treatment) 01/2018 - 01/2008
3	Nephrectomy 09/2016 - 10/2008
2	Prostatectomy (Retropubic Prostatectomy) 11/2021 - 11/2021
2	Orchiectomy (Orchidectomy) 03/2020 - 01/2008
2	Intravesical Administration 09/2014 - 01/2014
2	Renal Dialysis (Hemodialysis) 11/2012 - 12/2011
1	Decompression 01/2022
1	General Anesthesia 12/2021
1	Stem Cell Transplantation 01/2021